Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.89%
1,083.04
-9.76
-0.89%
—1,092.801,093.681,094.851,081.97——
SIXC
Communications
SIXC
Communications
SIXC
-0.39%
602.38
-2.36
-0.39%
—604.74604.74605.10601.34——
SIXE
Energy
SIXE
Energy
SIXE
+2.31%
1,242.83
+28.03
+2.31%
—1,214.801,220.811,243.821,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.62%
1,713.82
-10.75
-0.62%
—1,724.571,727.021,732.301,707.43——
SIXM
Financials
SIXM
Financials
SIXM
+0.09%
639.99
+0.56
+0.09%
—639.43641.58644.53637.50——
SIXR
Staples
SIXR
Staples
SIXR
-0.20%
837.46
-1.69
-0.20%
—839.15836.90840.48832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.65%
214.22
-1.40
-0.65%
—215.62215.62216.21213.48——
SIXT
Technology
SIXT
Technology
SIXT
+0.78%
3,204.38
+24.86
+0.78%
—3,179.523,191.503,205.093,177.75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.23%
925.38
-11.53
-1.23%
—936.91935.42937.17923.20——
SIXV
Health care
SIXV
Health care
SIXV
-0.69%
1,442.71
-10.06
-0.69%
—1,452.771,445.931,447.431,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.16%
2,361.34
-3.84
-0.16%
—2,365.182,353.642,368.102,347.80——
Q4 2026 earnings • released • Revenue beat +7.40%
See results
4503:TYO
Astellas Pharma Inc
¥2,183.50
-5.31%
(-122.50) 1D
Apr 30, 9:45:02 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4503...
Open
¥2,298
High
¥2,302
Low
¥2,177
Mkt. cap
4.02T
Avg. vol.
5.46M
Volume
3.59M
Dividend
3.57%
Quarterly dividend
¥19
Ex dividend date
Sep 29, 2025
P/E ratio
13.41
52-wk high
¥2,717
52-wk low
¥1,328
EPS
¥163
Shares outstanding
1.92B
No. of employees
14K
News stories
From sources across the web
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees13.6K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com
Last report
Apr 27, 2026
Fiscal Period
Q4 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
554.57B/ (516.35B est.)JPY
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
505.79B
524.32B
554.57B
554.57B
Cost of goods sold
94.83B
105.53B
104.03B
104.03B
Cost of revenue
94.83B
105.53B
104.03B
104.03B
Research and development expenses
71.70B
71.59B
85.77B
85.77B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
197.00B
206.84B
228.24B
228.24B
Operating expense
306.92B
325.88B
358.98B
358.98B
Total operating expenses
401.75B
431.41B
463.01B
463.01B
Operating income
104.04B
92.91B
91.55B
91.55B
Other non operating income
-1.00M
-
1.50M
1.50M
EBT including unusual items
90.42B
104.19B
90.99B
90.99B
EBT excluding unusual items
98.22B
92.38B
90.82B
90.82B
Income tax expense
21.99B
24.98B
19.02B
19.02B
Effective tax rate
24.33%
23.97%
20.90%
20.90%
Other operating expenses
5.46B
14.73B
9.72B
9.72B
Net income
68.42B
79.21B
71.95B
71.95B
Net profit margin
13.53%
15.11%
12.97%
12.97%
Earnings per share
-
-
-
-
Interest and investment income
1.67B
2.15B
2.10B
2.10B
Interest expense
-5.90B
-2.69B
-2.74B
-2.74B
Net interest expenses
-4.23B
-541.00M
-637.00M
-637.00M
Depreciation and amortization charges
-
-32.77B
-
-
EBITDA
151.84B
140.20B
141.30B
141.30B
Gain or loss from assets sale
-
16.40B
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer